1 / 12

Global Synthetic Biology Market to Expand at 32.60% CAGR till 2019 Thanks to Growing R&D Efforts

The global synthetic biology market will expand at a 32.60% CAGR during the forecast period from 2013 to 2019. In 2012, the global synthetic biology market was worth US$1.8 bn and by 2019, the market is expected to be worth US$13.4 bn. The global synthetic biology market is driven by the growing demand for improved drugs and vaccines.

priyap01
Download Presentation

Global Synthetic Biology Market to Expand at 32.60% CAGR till 2019 Thanks to Growing R&D Efforts

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Transparency Market Research Global Synthetic Biology Market to Expand at 32.60% CAGR till 2019 Thanks to Growing R&D Efforts Published Date 08-April-2014 143 Page Report Request Sample Buy Now Press Release http://www.transparencymarketresearch.com/pressrelease/cell-culture-market.htm Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com

  2. Breast Pumps Market REPORT DESCRIPTION Global Synthetic Biology Market to Expand at 32.60% CAGR till 2019 Thanks to Growing R&D Efforts The global synthetic biology market is projected to grow remarkably, says a report from Transparency Market Research (TMR). This report is titled “Synthetic Biology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”. The research study on the global synthetic biology market offers a 360-degree view of the market. According to this report, the global synthetic biology market will expand at a 32.60% CAGR during the forecast period from 2013 to 2019. In 2012, the global synthetic biology market was worth US$1.8 bn and by 2019, the market is expected to be worth US$13.4 bn. The global synthetic biology market is driven by the growing demand for improved drugs and vaccines. Furthermore, advancement in molecular biology will also fuel the global synthetic biology market. This trend is gaining traction in the market as the participation of government bodies and universities in research on synthetic biology is rising. Furthermore, the demand for genetically modified crops (GMOs) due to the expanding global population is also driving advancement in molecular biology. By product type, the global synthetic biology market is divided into core products (chassis organisms, XNA, synthetic cells, synthetic genes, and synthetic DNA) and enabling products (oligonucleotide synthesis and DNA synthesis). In 2012, the synthetic biology market was dominated by the synthetic DNA segment due to the higher commercial availability of this product as compared to other core products. On the basis of technology, the global synthetic biology market is divided into bioinformatics, DNA sequencing, genome engineering, and biological components and integrated systems. As genome engineering can be used for genetically 2 Transparency Market Research

  3. Breast Pumps Market modifying foods, gene therapy, and gene cloning, the application of genome engineering has grown, in turn driving the global synthetic biology market. Application-wise, the global synthetic biology market is segmented into agriculture, chemicals, healthcare, and others. The largest market share in the global synthetic biology market is held by the healthcare sector, as there is high utilization of synthetic biology techniques to make cheap vaccines and drugs. On the other hand, the agriculture application segment of the global synthetic biology market is expected to experience the highest growth during the forecast period. On the basis of geography, the global synthetic biology market is classified into Asia Pacific, Europe, North America, and Rest of the World (RoW). Europe held the largest market share in the global synthetic biology market in 2012 and is projected to grow consistently in the foreseeable future. The Europe synthetic biology market benefits from the efforts of government and private firms towards the development of this field. Funding for synthetic biology research in Europe is high. The start of the €70-bn Horizon 2020 program in Europe represents a pivotal moment for this regional synthetic biology market. Enquiry before Buying: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=421 Some of the key market players of the global synthetic biology market include Agrivida, Inc., Biosearch Technologies, Inc., DuPont, Inc., Evolva SA, Exxon Mobil Corporationand others. Market players are profiled in this report on the basis of attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments. Browse Full Press Release @ http://www.transparencymarketresearch.com/synthetic-biology-market.html TABLE OF CONTENT 3 Transparency Market Research

  4. Breast Pumps Market Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.4 List of Abbreviations Chapter 2 Executive Summary 2.1 Market Snapshot: Global Synthetic Biology Market (2012 & 2019) 2.1.1 Global Synthetic Biology Market by Technologies, 2012 (USD Million) 2.2 Comparative Analysis: Global Synthetic Biology Market, By Geography, 2012 and 2019 (Value %) Chapter 3 Market Overview 3.1 Introduction 3.2 Market Drivers 3.2.1 Drivers 3.2.1.1 Rising demand for improved drugs and vaccines 3.2.1.2 Advancement in molecular biology 3.2.1.3 Encouragement and participation of government bodies and universities in synthetic biology research 3.2.1.4 Increasing demand of genetically modified crops due to rising population 3.3 Market Restraints 3.3.1 Ethical Issues 3.4 Market Opportunities 3.4.1 Increasing clarity about metabolic pathways and nascent nature of synthetic biology concepts 3.5 Porter’s Five Force Analysis 3.5.1 Bargaining Power of Suppliers 3.5.2 Bargaining Power of Buyers 3.5.3 Threat of Substitutes 3.5.4 Threat of New Entrants 3.5.5 Competitive Rivalry 3.6 Market Attractiveness Analysis: Global Synthetic Biology Market, by Geography 4 Transparency Market Research

  5. Breast Pumps Market Chapter 4 Global Synthetic Biology Market, by Products 4.1 Introduction 4.1.1 Global Synthetic Biology Market Revenue, by Products, 2011 – 2019 (USD Million) 4.2 Core Products 4.2.1 Global Core Products Market Revenue, by Types, 2011 – 2019 (USD Million) 4.2.2 Synthetic DNA 4.2.2.1 Global Synthetic DNA Market Revenue, 2011 – 2019 (USD Million) 4.2.3 Synthetic Genes 4.2.3.1 Global Synthetic Genes Market Revenue, 2011 – 2019 (USD Million) 4.2.4 Synthetic Cells 4.2.4.1 Global Synthetic Cells Market Revenue, 2013 – 2019 (USD Million) 4.2.5 XNA (Xeno Nucleic Acid) 4.2.5.1 Global XNA Market Revenue, 2014 – 2019 (USD Million) 4.2.6 Chassis Organisms 4.2.6.1 Global Chassis Organisms Market Revenue, 2015 – 2019 (USD Million) 4.3 Enabling Products 4.3.1 Global Enabling Products Market Revenue, by Types, 2011 – 2019 (USD Million) 4.3.2 DNA Synthesis 4.3.2.1 Global DNA Synthesis Market Revenue, 2011 – 2019 (USD Million) 4.3.3 Oligonucleotide Synthesis 4.3.3.1 Global Oligonucleotide Synthesis Market Revenue, 2011 – 2019 (USD Million) Chapter 5 Global Synthetic Biology Market, by Technologies 5.1 Introduction 5.1.1 Global Synthetic Biology Market Revenue, by Technologies, 2011 – 2019 (USD Million) 5.2 Genome Engineering 5.2.1 Global Genome Engineering in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) 5.3 DNA Sequencing 5.3.1 Global DNA Sequencing in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) 5.4 Bioinformatics 5 Transparency Market Research

  6. Breast Pumps Market 5.4.1 Global Bioinformatics in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) 5.5 Biological Components and Integrated Systems 5.5.1 Global Biological Components and Integrated Systems in Synthetic Biology Market revenue, 2011 – 2019 (USD Million) Chapter 6 Global Synthetic Biology Market, by Applications 6.1 Introduction 6.1.1 Global Synthetic Biology Market Revenue, by Applications, 2011 – 2019 (USD Million) 6.2 Chemicals 6.2.1 Global Synthetic Biology in Chemicals, Market Revenue, 2011 – 2019 (USD Million) 6.3 Healthcare 6.3.1 Global Synthetic Biology in Healthcare Market Revenue, 2011 – 2019 (USD Million) 6.4 Agriculture 6.4.1 Global Synthetic Biology in Agriculture Market Revenue, 2011 – 2019 (USD Million) 6.5 Others (Biosecurity, R&D, Energy and Environment) 6.5.1 Global Synthetic Biology in Other Applications Market Revenue, 2011 – 2019 (USD Million) Chapter 7 Global Synthetic Biology Market, by Geography 7.1 Introduction 7.1.1 Global Synthetic Biology Market Revenue, by Geography, 2011 – 2019 (USD Million) 7.2 North America 7.2.1 North America Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) 7.3 Europe 7.3.1 Europe Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) 7.4 Asia-Pacific 7.4.1 Asia-Pacific Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) 7.5 Rest of the World (RoW) 7.5.1 RoW Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) Chapter 8 Competitive Landscape 8.1 Heat Map Analysis for Key Market Players 6 Transparency Market Research

  7. Breast Pumps Market 8.1.1 Amyris, Inc. 8.1.2 DuPont, Inc. 8.1.3 Royal DSM 8.1.4 Evolva Holding 8.1.5 Life Technologies Corporation 8.2 Heat Map Analysis of the Synthetic Biology Market, by Key Market Players, 2013 Chapter 9 Recommendations 9.1 Market Strategy for Success 9.1.1 Focus on investing in research and development activities 9.1.2 Strategic alliance, mergers and acquisitions 9.2 Barriers to be Considered 9.2.1 Ethical issues associated with synthetic biology products Chapter 10 Company Profiles 10.1 Agrivida, Inc. 10.1.1 Company Overview 10.1.2 Financial Overview 10.1.3 Product Portfolio 10.1.4 Business Strategies 10.1.5 Recent Developments 10.2 Amyris, Inc. 10.2.1 Company Profile 10.2.2 Financial Overview 10.2.3 Product Portfolio 10.2.4 Business Strategies 10.2.5 Recent Developments 10.3 Algenol Biofuels, Inc. 10.3.1 Company Overview 10.3.2 Financial Overview 10.3.3 Product Portfolio 7 Transparency Market Research

  8. Breast Pumps Market 10.3.4 Business Strategies 10.3.5 Recent Developments 10.4 ATG:biosynthetics GmbH 10.4.1 Company Overview 10.4.2 Financial Overview 10.4.3 Product Portfolio 10.4.4 Business Strategies 10.4.5 Recent Developments 10.5 Bayer AG 10.5.1 Company Overview 10.5.2 Financial Overview 10.5.3 Product Portfolio 10.5.4 Business Strategies 10.5.5 Recent Developments 10.6 Bristol-Myers Squibb 10.6.1 Company Overview 10.6.2 Financial Overview 10.6.3 Product Portfolio 10.6.4 Business Strategies 10.6.5 Recent Developments 10.7 BIONEER CORPORATION 10.7.1 Company Overview 10.7.2 Product Portfolio 10.7.3 Business Strategies 10.7.4 Recent Developments 10.8 Biosearch Technologies, Inc. 10.8.1 Company Overview 10.8.2 Financial Overview 10.8.3 Product Portfolio 10.8.4 Business Strategies 10.8.5 Recent Developments 8 Transparency Market Research

  9. Breast Pumps Market 10.9 CBC Comprehensive Biomarker Center GmbH 10.9.1 Company Overview 10.9.2 Financial Overview 10.9.3 Product Portfolio 10.9.4 Business Strategies 10.9.5 Recent Developments 10.10 Cobalt Technologies 10.10.1 Company Overview 10.10.2 Financial Overview 10.10.3 Product Portfolio 10.10.4 Business Strategies 10.10.5 Recent Developments 10.11 DuPont, Inc. 10.11.1 Company Overview 10.11.2 Financial Overview 10.11.3 Product Portfolio 10.11.4 Business Strategies 10.11.5 Recent Developments 10.12 Evolva SA 10.12.1 Company Overview 10.12.2 Financial Overview 10.12.3 Product Portfolio 10.12.4 Business Strategies 10.12.5 Recent Developments 10.13 Exxon Mobil Corporation 10.13.1 Company Overview 10.13.2 Financial Overview 10.13.3 Product Portfolio 10.13.4 Business Strategies 10.13.5 Recent Developments 10.14 Ginkgo Bioworks 9 Transparency Market Research

  10. Breast Pumps Market 10.14.1 Company Overview 10.14.2 Financial Overview 10.14.3 Product Portfolio 10.14.4 Business Strategies 10.14.5 Recent Developments 10.15 GeneWorks Pty Ltd. 10.15.1 Company Overview 10.15.2 Financial Overview 10.15.3 Product Portfolio 10.15.4 Business Strategies 10.15.5 Recent Developments 10.16 Genomatica, Inc. 10.16.1 Company Overview 10.16.2 Financial Overview 10.16.3 Product Portfolio 10.16.4 Business Strategies 10.16.5 Recent Developments 10.17 GeneScript Corporation 10.17.1 Company Overview 10.17.2 Financial Overview 10.17.3 Product Portfolio 10.17.4 Business Strategies 10.17.5 Recent Developments 10.18 Gevo, Inc. 10.18.1 Company Overview 10.18.2 Financial Overview 10.18.3 Product Portfolio 10.18.4 Business Strategies 10.18.5 Recent Developments 10.19 Green Biologics Limited 10.19.1 Company Overview 10 Transparency Market Research

  11. Breast Pumps Market 10.19.2 Financial Overview 10.19.3 Product Portfolio 10.19.4 Business Strategies 10.19.5 Recent Developments 10.20 New England Biolabs, Inc. 10.20.1 Company Overview 10.20.2 Financial Overview 10.20.3 Product Portfolio 10.20.4 Business Strategies 10.20.5 Recent Developments 10.21 OriGene Technologies, Inc. 10.21.1 Company Overview 10.21.2 Financial Overview 10.21.3 Product Portfolio 10.21.4 Business Strategies 10.21.5 Recent Developments 10.22 REG Life Sciences, LLC 10.22.1 Company Overview 10.22.2 Financial Overview 10.22.3 Product Portfolio 10.22.4 Business Strategies 10.22.5 Recent Developments 10.23 Royal DSM 10.23.1 Company Overview 10.23.2 Financial Overview 10.23.3 Product Portfolio 10.23.4 Business Strategies 10.23.5 Recent Developments 10.24 Thermo Fisher Scientific, Inc. 10.24.1 Company Overview 10.24.2 Financial Overview 11 Transparency Market Research

  12. Breast Pumps Market 10.24.3 Product Portfolio 10.24.4 Business Strategies 10.24.5 Recent Developments About Us Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ 12 Transparency Market Research

More Related